Moreover, celastrol reduces the level of IL-6 by inhibiting the NF-κB signaling pathway in breast cancer cells, inhibiting cell proliferation, migration, and invasion, thereby playing an anti-tumor role 77. This evidence concerns the gene NFKB1 and neoplasm.